Navigation Links
BioLife Solutions Announces HypoThermosol(R) and CryoStor(TM) Distribution Agreement With Sigma-Aldrich
Date:9/14/2009

. Sigma-Aldrich operates in 38 countries and has 7,800 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com.

About BioLife Solutions

BioLife Solutions develops, manufactures, and markets patented hypothermic storage/transport and cryopreservation media products for cells, tissues, and organs. The Company's proprietary HypoThermosol((R)) and CryoStor((TM)) platform of biopreservation media products are marketed to academic research institutions, hospitals, and commercial companies involved in cell therapy, tissue engineering, cord blood banking, drug discovery, and toxicology testing. BioLife's GMP products are serum-free and protein-free, fully defined, and pre-formulated to reduce preservation-induced, delayed-onset cell damage and death. Comprehensive small animal intravenous safety studies have been completed on HypoThermosol and CryoStor, and both products are supported by US FDA Master Files. BioLife's enabling technology provides research and clinical organizations significantly enhanced post-preservation cell and tissue viability and function. For more information please visit www.biolifesolutions.com.

This news release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements include any statements that relate to the intent, belief, plans or expectations of the Company or its management, or that are not a statement of historical fact. Any forward-looking statements in this news re
'/>"/>

SOURCE BioLife Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
2. BioLife Solutions Expands Scientific Advisory Board
3. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
4. BioLife Solutions Outsourcing Manufacturing, Warehousing, and Order Fulfillment to Bioserv Corporation
5. BioLife Solutions Announces FDA Master File Acceptance for CryoStor(TM) Pre-formulated Cryopreservation Media
6. BioLife Solutions Credit Facility Increased to $9 Million
7. BioLife Solutions HypoThermosol(R) Adopted by MicroIslet for Processing Pancreatic Islet Cells to Treat Diabetes
8. BioLife Solutions Submits FDA Master File on HypoThermosol(R) Preservation and Storage Media for Cells, Tissues
9. BioLife Solutions Granted European Biopreservation Patent
10. BioLife Solutions Completes Safety Studies on HypoThermosol(R) and CryoStor(TM)
11. BioLife Solutions Joins Prestigious Biomedical Excellence for Safer Transfusion Collaborative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... CA (PRWEB) June 18, 2013 (PRWEB) June 18, ... #1 time and attendance system in North America, ... that shares employee data and payroll records between ... AccountLinx Plus automates ExakTime software setup and ... software imports employee data from a business’ current ...
(Date:6/18/2013)... Miami, FL (PRWEB) June 18, 2013 The ... associate the skin as an important human body part. Similar ... cared for in order to function, repair and grow. Recent ... with vitamins and supplements, is just as important as other ... and supplements to aid in skin cell reproduction, increase the ...
(Date:6/18/2013)... RegeneCure announced today the start of ... Regeneration (GBR) Dental Membrane as a bone stimulating aid for ... when patients have a tooth replaced with a dental implant ... implant. Consequently there is often a need to support the ... The bone substitute material, in turn, needs to be held ...
(Date:6/18/2013)... 2013 Edison Investment ... announces the initiation of full coverage of ... developing and marketing products for orphan oncology ...      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) Edison has ... investment merits of BioAlliance Pharma, focusing in ...
Breaking Biology Technology:ExakTime Introduces AccountLinx Plus 2Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3
... March 18 Ingenuity Systems, the,leading provider ... has,announced that they have extended and expanded ... to Ingenuity Pathways Analysis,(IPA) software. The new ... to researchers for rapid assessment of the ...
... engineer genetic modifications, thereby providing scientists with a ... food production to drug discovery. However, this sophisticated ... threat of engineered pathogens. New research published in ... that computational tools could become a vital resource ...
... New Monograph Strengthens Safety Nets to Prevent Serious Health ... ... 17 The U.S. Pharmacopeial (USP),Convention today announced a ... official compendium of the United States. The,revision strengthens safety ...
Cached Biology Technology:Ingenuity Systems Extends Enterprise-Level Software Agreement With GlaxoSmithKline 2On the trail of rogue genetically modified pathogens 2USP Announces Revised Glycerin Monograph 2USP Announces Revised Glycerin Monograph 3
(Date:6/19/2013)... for human consumption qualifies as a gluten-free cereal that ... scientists have confirmed in a study published in ACS, ... , Joyce Irene Boye and colleagues point out that ... alone have CD. They develop gastrointestinal and other symptoms ... contain gluten-related proteins. Boye,s team sought to expand dietary ...
(Date:6/19/2013)... fall 2012, the European Medicines Agency (EMA) approved ... first ever gene therapy for clinical use in ... had developed AAV-LPL S447X for the treatment of ... deficiency (LPLD) which affects approximately one or two ... severe, life-threatening inflammations of the pancreas. Afflicted individuals ...
(Date:6/18/2013)... A UT Arlington environmental engineer has been awarded ... District to ensure water quality and flow in ... Project. , Andrew Kruzic, UT Arlington associate professor ... and locations to add monochloramine to the water ... the new pump stations and pipelines. Adding monochloramine ...
Breaking Biology News(10 mins):No danger of cancer through gene therapy virus 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2
... -- The number of overweight and obese Americans continues to ... up to 20 percent are obese. While the number of ... increase of overweight infants -- individuals under 11 months old ... pregnant women who are overweight/obese are more likely to give ...
... Elsevier announced today that it is launching a ... Engineering. The journal will be published bimonthly, and will ... of natural gas science and engineering. The first issue ... Natural Gas Science and Engineering will cover the fields ...
... Ohio State University have found that the number of copies ... cancer in a mouse model. Publishing in the Jan. 3 ... or Down syndrome in humans, can repress tumor growth. ... whether people with Down syndrome develop cancer less often than ...
Cached Biology News:Mom's obesity during conception phase may set the stage for offspring's obesity risk 2Mom's obesity during conception phase may set the stage for offspring's obesity risk 3Mom's obesity during conception phase may set the stage for offspring's obesity risk 4Elsevier launches new journal: Journal of Natural Gas Science and Engineering 2Gene dose affects tumor growth 2
Immunogen: Purified native p24 from strain IIIB. Storage: -20 C, Avoid Freeze/Thaw Cycles...
EDG-1CT (endothelial cell differentiation gene-1, C terminal)...
Request Info...
... epitope is specific for Kir2.1 and ... known protein.,SPECIES REACTIVITIES: The immunogen ... porcine and guinea pig. It is ... (17/19 residues) and chick (15/19 residues). ...
Biology Products: